On average, a clinical trial improves the Swedish GDP by SEK 1m and the public budget by SEK 0,9m. The positive economic effects arise from trials conducted in Sweden through several drivers; by contributing to more and better healthcare, by creating highly productive jobs and by drug costs savings.
In this study, we were asked to quantify the value generated by clinical trials in Sweden to shed light on the benefits of conducting trials. We find, that on top of economic benefits, clinical trials further has a positive effect on competency development in the health care sector as well as on future research.
For further information, please contact Sofia Nyström